DRC & Research News

This page shares the latest news in T1D research and DRC’s community.

Get the most recent diabetes research news, delivered straight to your inbox

Enterovirus

Detection of Enterovirus Infection in Insulin Producing Cells in Patients Newly Diagnosed with Type 1 Diabetes

EnterovirusNorwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low-grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.

The discovery provides possibility for both antiviral treatment and vaccine of type 1 diabetes, according to a press release from The University of Oslo. Type 1 diabetes affects young people and children. Unlike type 2, type 1 cannot be treated by diet changes and exercise Insulin is needed. Only 29 % of the patients reach the recommended goals for treatment to prevent disabling late diabetes complications.

The Diabetes Virus Detection study (DiViD) is the first to examine fresh pancreatic tissue at the diagnosis of type 1 diabetes for the presence of viruses. Minimal pancreatic tail resection was performed 3-9 weeks after onset of type 1 diabetes in 6 adult patients (age 24-35 years).

The presence of enteroviral capsid protein 1 (VP1) and the expression of class I HLA were investigated by immunohistochemistry. Enterovirus RNA was analyzed from isolated pancreatic islets and from fresh frozen whole pancreatic tissue using PCR and sequencing. Non-diabetic organ donors served as controls. VP1 was detected in the islets of all type 1 diabetes patients (2 of 9 controls).

Hyperexpression of class I HLA molecules was found in the islets of all patients (1 of 9 controls).

Enterovirus specific RNA sequences were detected in 4 of 6 cases (0 of 6 controls). The results were confirmed in different laboratories. Only 1.7 % of the islets contained VP1 positive cells and the amount of enterovirus RNA was low. The results provides evidence for the presence of enterovirus in pancreatic islets of type 1 diabetic patients, being consistent with the possibility that a low grade enteroviral infection in the pancreatic islets contribute to disease progression in humans.


Story Source:

The above story is based on materials provided by Oslo University HospitalNote: Materials may be edited for content and length.


Journal Reference:

  1. L. Krogvold, B. Edwin, T. Buanes, G. Frisk, O. Skog, M. Anagandula, O. Korsgren, D. Undlien, M. Eike, S. J. Richardson, P. Leete, N. G. Morgan, S. Oikarinen, M. Oikarinen, J. E. Laiho, H. Hyoty, J. Ludvigsson, K. F. Hanssen, K. Dahl-Jorgensen. Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetesDiabetes, 2014; DOI: 10.2337/db14-1370

Cite This Page:

Oslo University Hospital. “Detection of enterovirus infection in insulin producing cells in patients newly diagnosed with type 1 diabetes.” ScienceDaily. ScienceDaily, 15 December 2014. <www.sciencedaily.com/releases/2014/12/141215114103.htm>.

 

Learn More +

OUR PROJECTS

See our approved research projects and campaigns.

Role of the integrated stress response in type 1 diabetes pathogenesis
In individuals with type 1 diabetes (T1D), the insulin-producing beta cells are spontaneously destroyed by their own immune system. The trigger that provokes the immune system to destroy the beta cells is unknown. However, accumulating evidence suggest that signals are perhaps first sent out by the stressed beta cells that eventually attracts the immune cells. Stressed cells adapt different stress mitigation systems as an adaptive response. However, when these adaptive responses go awry, it results in cell death. One of the stress response mechanisms, namely the integrated stress response (ISR) is activated under a variety of stressful stimuli to promote cell survival. However, when ISR is chronically activated, it can be damaging to the cells and can lead to cell death. The role of the ISR in the context of T1D is unknown. Therefore, in this DRC funded study, we propose to study the ISR in the beta cells to determine its role in propagating T1D.
Wearable Skin Fluorescence Imaging Patch for the Detection of Blood Glucose Level on an Engineered Skin Platform
zhang
A Potential Second Cure for T1D by Re-Educating the Patient’s Immune System
L Ferreira
Validating the Hypothesis to Cure T1D by Eliminating the Rejection of Cells From Another Person by Farming Beta Cells From a Patient’s Own Stem Cells
Han Zhu
Taming a Particularly Lethal Category of Cells May Reduce/Eliminate the Onset of T1D
JRDwyer 2022 Lab 1
Can the Inhibition of One Specific Body Gene Prevent Type 1 Diabetes?
Melanie
Is Cholesterol Exacerbating T1D by Reducing the Functionality and Regeneration Ability of Residual Beta Cells?
Regeneration Ability of Residual Beta Cells
A Call to Question… Is T1D Caused by Dysfunctionality of Two Pancreatic Cells (β and α)?
Xin Tong
Novel therapy initiative with potential path to preventing T1D by targeting TWO components of T1D development (autoimmune response and beta-cell survival)
flavia pecanha